MDSC targeting with Gemtuzumab ozogamicin restores T cell immunity and immunotherapy against cancers

Research output: Contribution to journalArticlepeer-review

38 Citations (Scopus)
321 Downloads (Pure)

Fingerprint

Dive into the research topics of 'MDSC targeting with Gemtuzumab ozogamicin restores T cell immunity and immunotherapy against cancers'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Immunology and Microbiology